3,257 results match your criteria: "School of Medicine at University of California[Affiliation]"
Neurobiol Sleep Circadian Rhythms
November 2024
Semel Institute, Department of Psychiatry & Biobehavioral Sciences, University of California Los Angeles, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, USA.
Neurobiol Dis
January 2025
IDDRC, Jane and Terry Semel Institute for Neuroscience & Human Behavior, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, CA, USA.
There is a growing consensus that brain development in Huntington's disease (HD) is abnormal, leading to the idea that HD is not only a neurodegenerative but also a neurodevelopmental disorder. Indeed, structural and functional abnormalities have been observed during brain development in both humans and animal models of HD. However, a concurrent study of cortical and striatal development in a genetic model of HD is still lacking.
View Article and Find Full Text PDFNat Commun
December 2024
Cancer Metabolism and Microenvironment Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA, USA.
J Thorac Oncol
November 2024
Department of Thoracic Oncology, LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.
Introduction: RELAY, a global double-blind, placebo-controlled phase 3 study (NCT02411448) found statistically significant improvement in progression-free survival (primary end point) for ramucirumab (RAM) plus erlotinib (ERL) (RAM + ERL) in patients with untreated EGFR-mutated metastatic NSCLC (hazard ratio [HR] = 0.59, 95% confidence interval [CI]: 0.46-0.
View Article and Find Full Text PDFJ Glob Antimicrob Resist
November 2024
Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California (USC), Los Angeles, CA, USA.
Background: Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (N. gonorrhoeae) is an urgent global health concern. Commensal Neisseria species in the oropharynx are an important reservoir of AMR genes that are transferred to N.
View Article and Find Full Text PDFCurr Opin Nephrol Hypertens
January 2025
Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles.
Toxicol Appl Pharmacol
November 2024
Division of Cardiology, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California, United States of America; Department of Environmental Health Sciences, Fielding School of Public Health at University of California Los Angeles, Los Angeles, California, United States of America; Environmental and Molecular Toxicology Interdepartmental Program, University of California Los Angeles, Los Angeles, California, United States of America; Molecular Biology Institute, University of California Los Angeles, Los Angeles, California, United States of America. Electronic address:
Prim Care Companion CNS Disord
November 2024
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California.
Surg Endosc
November 2024
Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, CA, USA.
Background: Orchialgia is a rare but significant complication experienced after open and minimally invasive inguinal hernia repairs with or without mesh. Causes have been theorized to include trauma to the spermatic cord, mesh-induced inflammation, vascular insult, fibrosis or mesh scarring of the cord, and neuropathic injury to the autonomic paravasal nerve fibers supplying the testicle. Though less frequently described than inguinodynia, orchialgia can be severely debilitating.
View Article and Find Full Text PDFJ Am Acad Dermatol
November 2024
Division of Dermatology, Department of Medicine, David Geffen School of Medicine at University of California Los Angeles, Los Angeles, California. Electronic address:
J Trauma Acute Care Surg
November 2024
From the Cardiovascular Outcomes Research Laboratories (CORELAB) (T.N.C., A.V., J.B., N.Y.C., P.B.), David Geffen School of Medicine at University of California; Department of Surgery (A.S., G.B.), Cedars-Sinai Medical Center; and Division of Cardiac Surgery, Department of Surgery (P.B.), David Geffen School of Medicine, University of California, Los Angeles, California.
Orthop J Sports Med
November 2024
Luminis Health Orthopedics, Pasadena, Maryland, USA.
Background: As machine learning becomes increasingly utilized in orthopaedic clinical research, the application of machine learning methodology to cohort data from the Multicenter ACL Revision Study (MARS) presents a valuable opportunity to translate data into patient-specific insights.
Purpose: To apply novel machine learning methodology to MARS cohort data to determine a predictive model of revision anterior cruciate ligament reconstruction (rACLR) graft failure and features most predictive of failure.
Study Design: Cohort study; Level of evidence, 3.
JTCVS Open
October 2024
Cardiovascular Outcomes Research Laboratories (CORELAB), Department of Surgery, David Geffen School of Medicine at University of California, Los Angeles, Calif.
Prostate
February 2025
Department of Translational Medicine, Division of Urological Cancers, Lund University, Malmö, Sweden.
Background: The transcription factor Signal Transducer and Activator of Transcription 3 (STAT3) plays a role in carcinogenesis and is involved in processes, such as proliferation, differentiation, drug resistance and immunosuppression. STAT3 can be activated by phosphorylation of tyrosine at position 705 (pSTAT3) or serine at 727 (pSTAT3). High expression levels of pSTAT3 are implicated in advanced stages of prostate cancer (PCa) and are known to interact with the androgen receptor signaling pathway.
View Article and Find Full Text PDFClin Infect Dis
November 2024
Pfizer Research and Development, Pfizer Inc, 2002 N Tampa Street, 2nd Floor, Tampa, FL 33602, USA.
Background: Nirmatrelvir/ritonavir (NMV/r) is an oral antiviral treatment for mild to moderate COVID-19.
Methods: This phase 2/3, double-blind, randomized (1:1) study assessed oral NMV/r 300 mg/100 mg versus placebo every 12 hours for 5 days in high-risk, unvaccinated, nonhospitalized, symptomatic adults with COVID-19 from 343 sites across 21 countries. In testing the primary endpoint of COVID-19‒related hospitalization and all-cause deaths and key secondary endpoints including symptom duration and COVID-19‒related medical visits, Type I error was controlled with prespecified sequential testing and the Hochberg procedure.
Int J Mol Sci
October 2024
The Lundquist Institute for Biomedical Innovation, Torrance, CA 90502, USA.
Cancer Med
November 2024
Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Background: Rising metastatic prostate cancer incidence has renewed debate regarding benefits of prostate-specific antigen (PSA) screening. Identifying barriers to accessing screening for individuals at high risk of lethal prostate cancer may slow this rise. We examined associations of access barriers with receipt of PSA testing, stratified by sociodemographic factors.
View Article and Find Full Text PDFCerebrovasc Dis
November 2024
Department of Neurology, David Geffen School of Medicine at University of California - Los Angeles, Los Angeles, California, USA.
Introduction: Stroke mortality has declined, with differential changes by race; stroke is now the 5th leading cause of death overall, but 2nd leading cause of death in Black individuals. Little is known about recent race/ethnic and sex trends in in-hospital mortality after acute ischemic stroke (AIS) and whether system-level factors contribute to possible differences.
Methods: Using the National Inpatient Sample, adults (≥18 years) with a primary diagnosis of AIS from 2006 to 2017 (n = 643,912) were identified.
Otolaryngol Head Neck Surg
November 2024
Department of Otolaryngology-Head and Neck Surgery, Keck School of Medicine of the University of Southern California, Los Angeles, California, USA.
Objective: Human papillomavirus (HPV) is a significant driver of elevated risk for oropharyngeal squamous cell carcinoma (OPSCC). In 2018, HPV vaccination eligibility was expanded to men and women aged 27 to 45. We evaluated changes in awareness of HPV, its association with OPSCC, and HPV vaccination among all US adults between 2018 and 2020, focusing on those aged 27 to 45.
View Article and Find Full Text PDFArthritis Rheumatol
November 2024
New York University Grossman Long Island School of Medicine, Mineola, New York.
Structure
December 2024
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California Mann School of Pharmacy and Pharmaceutical Sciences, 1985 Zonal Avenue, Los Angeles, CA 90089-9121, USA. Electronic address:
Fibril-type aggregates of tau occur in Alzheimer's disease (AD) and dozens of tauopathies. Fibrils catalyze aggregation by prion-like seeding, which in part underlies disease progression. Seeding by recombinant and brain-derived tau fibrils is measured using biosensor cells that express aggregation-prone tau mutants fused with fluorescent reporter proteins.
View Article and Find Full Text PDFFASEB J
November 2024
The Lundquist Institute for Biomedical Innovation, Torrance, California, USA.
The role of long non-coding RNAs in fibroid pathogenesis remains largely unexplored. In a previous study, we found elevated XIST (X-inactive specific transcript) levels in fibroids, which sponged miR-29c and miR-200c, leading to the overexpression of their target genes. This study aimed to assess the therapeutic potential of XIST downregulation in fibroid treatment.
View Article and Find Full Text PDFAm J Health Promot
October 2024
Department of Family Medicine, David Geffen School of Medicine at University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Purpose: Community members and non-academic partners ("affected groups") were asked to identify factors that can influence public support, impede adoption, and mitigate challenges related to adopting local smoke-free multi-unit housing policies.
Approach: A series of key informant interviews were conducted with affected groups from a large U.S.
Urology
January 2025
David Geffen School of Medicine at University of California, Los Angeles, CA. Electronic address:
Background: Six randomized trials have not detected a difference between intravenous alteplase plus endovascular thrombectomy and endovascular thrombectomy alone in stroke. Tenecteplase, a recombinant human tenecteplase tissue-type plasminogen activator, is a genetically modified variant of alteplase. It is unclear whether the outcomes are different if alteplase is replaced with tenecteplase.
View Article and Find Full Text PDF